Structure of Pitavastatin
CAS No.: 147511-69-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Pitavastatin is a potent HMG-CoA reductase inhibitor and inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in a human liver cancer cell line (HepG2).
Synonyms: NK-104
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 147511-69-1 |
Formula : | C25H24FNO4 |
M.W : | 421.46 |
SMILES Code : | O=C(O)C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N=C1C4CC4 |
Synonyms : |
NK-104
|
MDL No. : | MFCD04113054 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H361 |
Precautionary Statements: | P201-P202-P280-P308+P313-P405-P501 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT02107898 | Hypercholesterolemia | Phase 3 | Completed | - | Japan ... More >> Investigational Site Number 392016 Adachi-Ku, Japan Investigational Site Number 392029 Adachi-Ku, Japan Investigational Site Number 392024 Aki-Gun, Japan Investigational Site Number 392012 Chuo-Ku, Japan Investigational Site Number 392013 Chuo-Ku, Japan Investigational Site Number 392032 Fukui-Shi, Japan Investigational Site Number 392004 Hakusan-Shi, Japan Investigational Site Number 392028 Kaga-Shi, Japan Investigational Site Number 392002 Kanazawa-Shi, Japan Investigational Site Number 392005 Kanazawa-Shi, Japan Investigational Site Number 392023 Kawanishi-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392026 Kitakyushu-Shi, Japan Investigational Site Number 392003 Komatsu-Shi, Japan Investigational Site Number 392011 Kuki-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392007 Mito-Shi, Japan Investigational Site Number 392006 Moriya-Shi, Japan Investigational Site Number 392018 Nagoya-Shi, Japan Investigational Site Number 392014 Oota-Ku, Japan Investigational Site Number 392019 Osaka-Shi, Japan Investigational Site Number 392020 Osaka-Shi, Japan Investigational Site Number 392022 Osaka-Shi, Japan Investigational Site Number 392030 Osaka-Shi, Japan Investigational Site Number 392027 Oyabe-Shi, Japan Investigational Site Number 392010 Saitama-Shi, Japan Investigational Site Number 392015 Shinjuku-Ku, Japan Investigational Site Number 392031 Shizuoka-Shi, Japan Investigational Site Number 392021 Suita-Shi, Japan Investigational Site Number 392025 Takamatsu-Shi, Japan Investigational Site Number 392008 Tsuchiura-Shi, Japan Investigational Site Number 392001 Yamagata-Shi, Japan Less << |
NCT02107898 | - | Completed | - | - | |
NCT01502904 | Stable Angina or Acute Coronar... More >>y Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less << |
NCT01890967 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT01890967 | - | Completed | - | - | |
NCT02743260 | Healthy | Phase 4 | Unknown | December 2017 | Germany ... More >> Department of Pharmacology I, University Hospital Cologne Cologne, NRW, Germany, 50931 Less << |
NCT02888327 | Influenza in Humans | Phase 1 | Completed | - | United Kingdom ... More >> Hammersmith Medicines Research London, United Kingdom Less << |
NCT03418974 | Dyslipidemias | Phase 4 | Active, not recruiting | December 31, 2021 | China, Beijing ... More >> Heart Center of Peking University People's Hospital Beijing, Beijing, China, 100044 China, Shanghai School of Public Health, Fudan University Shanghai, Shanghai, China, 200032 Less << |
NCT00723398 | - | Completed | - | - | |
NCT01265706 | - | Completed | - | Korea, Republic of ... More >> Chonnam National University Hospital Gwangju, Korea, Republic of Less << | |
NCT00716846 | Healthy Volunteers | Not Applicable | Completed | - | Japan ... More >> Hamamatsu University School of Medicine Hamamatsu, Japan Less << |
NCT00723398 | Breast Cancer | Not Applicable | Completed | - | United States, Pennsylvania ... More >> Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less << |
NCT00805714 | - | Completed | - | Korea, Republic of ... More >> Cardiac and Vascular Center, Hanseo Hospital Busan, Korea, Republic of Departments of Cardiology, Catholic University of Daegu College of Medicine Daegu, Korea, Republic of Division of Cardiology, Department of Internal Medicine, School of Medicine, Keimyung University Daegu, Korea, Republic of Division of Cardiology, Heart Center, Konyang University Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Department of Cardiovascular Medicine, Wonkwang University School of Medicine Iksan, Korea, Republic of Gachon University Gil Medical Center In Cheon, Korea, Republic of Division of Cardiology Cardiac Center, Seoul National University Bundang Hospital Seongnam, Korea, Republic of Cardiovascular Center, Korea University Guro Hospital Seoul, Korea, Republic of Heart Center, Division of Cardiology, Chung-Ang University Hospital Seoul, Korea, Republic of Less << | |
NCT00548145 | Alzheimer Disease ... More >> Hypercholesterolemia Less << | Not Applicable | Terminated | - | Japan ... More >> Osaka University Hospital Suita, Osaka, Japan, 565-0871 Less << |
NCT00548145 | - | Terminated | - | - | |
NCT01710007 | Hypercholesterolemia | Phase 3 | Completed | - | Taiwan ... More >> Buddhist Taipei TzuChi General Hospital New Taipei City, Taiwan, 23142 Cardinal Tien Hospital New Taipei City, Taiwan, 231 Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan, 23561 Taichung Veterans General Hospital Taichung City, Taiwan, 40705 Taipei Veterans General Hospital Taipei City, Taiwan, 11217 Cheng Hsin General Hospital Taipei City, Taiwan, 112 Tri-Service General Hospital Taipei City, Taiwan, 114 Chang Gung Medical Foundation- LinKuo Branch Taoyuan City, Taiwan, 333 Less << |
NCT01223586 | - | Completed | - | Japan ... More >> Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 Division of Cardiology, Kyoto University Hospital Kyoto, Japan, 606-8507 Less << | |
NCT01660191 | - | Completed | - | - | |
NCT03606824 | Dyslipidemia ... More >>Subclinical hypothyro?dism Lipid-Lowering Therapy Statin Less << | Not Applicable | Not yet recruiting | March 1, 2020 | - |
NCT00701285 | Chronic Heart Failure | Phase 4 | Completed | - | Korea, Republic of ... More >> SEOUL St. Mary's Hospital Seoul, Seocho-Ku, Korea, Republic of, 137-040 Less << |
NCT00549926 | Coronary Disease ... More >> Hypercholesterolemia Less << | Phase 4 | Completed | - | Japan ... More >> Yokohama City University Medical Center Yokohama, Japan Less << |
NCT01660191 | Hypercholesterolemia | Phase 4 | Completed | - | United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less << |
NCT02634034 | Hyperlipidemia | Phase 1 | Completed | - | United States, Texas ... More >> Austin, Texas, United States, 78744 Less << |
NCT02799758 | Hyperlipidemia ... More >> Dyslipidemia Less << | Phase 3 | Terminated | November 2017 | - |
NCT03311841 | Renal Insufficiency | Phase 1 | Completed | - | United States, Florida ... More >> Clinical Pharmacology of Miami ( Site 0001) Hialeah, Florida, United States, 33014 Orlando Clinical Research Center ( Site 0002) Orlando, Florida, United States, 32809 Less << |
NCT01178853 | Healthy | Phase 4 | Completed | - | United States, Texas ... More >> Austin, Texas, United States Less << |
NCT02670434 | Hyperlipidemia ... More >> Dyslipidemia Less << | Phase 3 | Terminated | October 2017 | - |
NCT02344290 | HIV Infections ... More >> Cardiovascular Diseases Less << | Phase 3 | Recruiting | April 1, 2022 | - |
NCT00249249 | - | Completed | - | - | |
NCT00249249 | Primary Hypercholesterolemia ... More >> Dyslipidemia Less << | Phase 3 | Completed | - | - |
NCT00242944 | Coronary Disease ... More >> Hypercholesterolemia Less << | Phase 4 | Completed | - | Japan ... More >> Juntendo University School of Medicine Bunkyo-ku, Tokyo, Japan, 113-8421 Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 Kyoto University Graduate School of Medicine Kyoto, Japan, 606-8507 Less << |
NCT01232049 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less << |
NCT03070223 | - | Active, not recruiting | February 28, 2022 | - | |
NCT02250976 | Healthy Male Volunteers | Phase 1 | Completed | - | Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less << |
NCT01178853 | - | Completed | - | - | |
NCT00257686 | Hypercholesterolemia or Combin... More >>ed Dyslipidemia Less << | Phase 3 | Completed | - | - |
NCT01767610 | Healthy Male Volunteers | Phase 1 | Completed | - | Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less << |
NCT00711919 | Hyperlipidemia ... More >> Carotid Artery Diseases Less << | Not Applicable | Unknown | - | Japan ... More >> Ayabe City Hospital Ayabe, Kyoto, Japan, 623-0011 Fukuchiyama City Hospital Fukuchiyama, Kyoto, Japan, 620‐8505 Tanabe Central Hospital Kyotanabe, Kyoto, Japan, 610-0334 Kumihama Hospital Kyotango, Kyoto, Japan, 629-3400 Maizuru Medical Center Maizuru, Kyoto, Japan, 625-8502 Maizuru Kyosai Hospital Maizuru, Kyoto, Japan, 625-8585 Saiseikai Kyoto Hospital Nagaokakyo, Kyoto, Japan, 617-0814 Nantan General Hospital Nantan, Kyoto, Japan, 629-0197 Meiji University of Integrative Medicine Hospital Nantan, Kyoto, Japan, 629-0392 Gakken Toshi Hospital Seika, Kyoto, Japan, 619-0238 Uji Hospital Uji, Kyoto, Japan, 611-0011 Kyoto Prefectural Yosanoumi Hospital Yosano, Kyoto, Japan, 629-2261 Shiga Hospital Higashioumi, Shiga, Japan, 527-8505 Omihachiman Community Medical Center Omihachiman, Shiga, Japan, 523-0082 Saiseikai Shigaken Hospital Rittou, Shiga, Japan, 520-3046 Takeda Hospital Kyoto, Japan, 600-8558 Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Kyoto First Red Cross Hospital Kyoto, Japan, 605-0981 Less << |
NCT00861861 | Hypercholesterolemia ... More >> Coronary Artery Disease Less << | Phase 4 | Completed | - | Japan ... More >> Kumamoto University Graduate School of Medical Sciences Department of Cardiocascular Medicine Kumamoto, Japan, 860-8556 Less << |
NCT00257686 | - | Completed | - | - | |
NCT02956590 | Dyslipidemia ... More >>Obesity Less << | Phase 3 | Recruiting | May 31, 2022 | United States, Delaware ... More >> Nemours/Alfred I duPont Hospital for Children Not yet recruiting Wilmington, Delaware, United States, 19803 Contact: Samuel Gidding, MD sgidding@nemours.org Principal Investigator: Samuel Gidding, MD United States, District of Columbia Children's National Health System Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Michele Mietus-Snyder, MD mmsynder@childrensnational.org Principal Investigator: Michele Mietus-Snyder, MD United States, Georgia Emory University School of Medicine Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Miriam Voss, MD, MSPH mvos@emory.edu Principal Investigator: Miriam Vos, MD, MSPH United States, Indiana Riley Hospital for Children at IU Health Not yet recruiting Indianapolis, Indiana, United States, 46202 Contact: Jacqueline Maiers, MD jmaiers@iu.edu Principal Investigator: Jacqueline Maiers, MD United States, Massachusetts Boston Children's Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Sarah de Ferranti, MD, MPH sarah.deferranti@cardio.chboston.org Principal Investigator: Sarah de Ferranti, MD, MPH United States, Michigan University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Caren Goldberg, MD, MS cgoldberg@umich.edu Principal Investigator: Caren Goldberg, MD, MS United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Nicolas Madsen, MD, MPH nicolas.madsen@cchmc.org Principal Investigator: Nicolas Madsen, MD, MPH United States, Pennsylvania The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Julie Brothers, MD, FAAP brothersj@email.chop.edu Principal Investigator: Julie Brothers, MD, FAAp Children's Hospital of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Silva Arslanian, MD silva.arslanian@chp.edu Principal Investigator: Silva Arslanian, MD United States, South Carolina Medical University of South Carolina Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Andrew Atz, MD atzam@musc.edu Principal Investigator: Andrew Atz, MD United States, Texas Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: S. Kristen Sexson, MD, Phd sxsexson@texaschildrens.org Principal Investigator: S. Kristen Sexson, MD, Phd United States, Utah Primary Children's Hospital, University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84108 Contact: Adam Ware, MD adam.ware@hsc.utah.edu Principal Investigator: Adam Ware, MD Canada, Ontario The Hospital for Sick Children Not yet recruiting Toronto, Ontario, Canada, M5g 1X8 Contact: Brian McCrindle, MD, MPH brian.mccrindle@sickkids.ca Principal Investigator: Brian McCrindle, MD, MPH Less << |
NCT00344175 | Hypercholesterolemia ... More >> Dyslipidemia Coronary Heart Disease Less << | Phase 3 | Completed | - | Denmark ... More >> Y Forskning, Bispebjerg Hospital Copenhagen Nv, Denmark Frederiks Hospital, Kardiologisk Frederiksberg, Denmark Kolesterollaboratoriet Hellerup, Denmark CCBR A/S Vejle, Denmark Netherlands Middellaan 5 Breda, Netherlands Bomanshof 8 Eindhoven, Netherlands Damsterdiep 9 Groningen, Netherlands Doezastraat 1 Leiden, Netherlands Kamerlingh Onnesstraat 16-18 Nijmegen, Netherlands Mathenesserlaan 247 Rotterdam, Netherlands Reigerstraat 30 Velp, Netherlands Parkdreef 142 Zoetermeer, Netherlands Spain Hospital Clinico S. Juan de Alicante San Juan, Alicante, Spain Hospital Universitario Reina Sofia Cordoba, Spain Hospital Ramon y Cajal Madrid, Spain, 28000 Fundacion Jimenez Diaz Madrid, Spain Hospital Clinico San Carlos Madrid, Spain Hospital Clinico Universitario de Santiago Santiago de Compostela, Spain Sweden Angelholms Sjukhus, Medicinkliniken Angelhom, Sweden Sahlgrenska University Hospital, Intermedicin Gothenburg, Sweden Hjartmottagningen Helsingborg, Sweden Lakarcentrum Nyponet Karineholm, Sweden Medicinkliniken Ludvika, Sweden Huslakaren i Sandviken Sandviken, Sweden Narsjukhuset Sandviken, Kardiologlab, Medicin Sandviken, Sweden Hjart & Karlcenter Sodertalje, Sweden Karolinska Universitetssjukhuset Stockholm, Sweden Hjarthuset AB Varberg, Sweden Less << |
NCT00344175 | - | Completed | - | - | |
NCT01166633 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00640276 | Hypercholesterolemia ... More >> Metabolic Syndrome Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Seoul National University Bundang Hospital Bundang-gu, Gyeonggi-do, Korea, Republic of, 463-707 Hanyang Univ. Guri Hospital Guri-si, Gyeonggi-do, Korea, Republic of, 471-701 Less << |
NCT00309738 | - | Completed | - | - | |
NCT00309777 | Hypercholesterolemia ... More >> Dyslipidemia Less << | Phase 3 | Completed | - | - |
NCT01057433 | Healthy Volunteers | Phase 4 | Completed | - | United States, Texas ... More >> Austin, Texas, United States Less << |
NCT00301392 | Diabetes Mellitus ... More >> Glucose Intolerance Less << | Phase 4 | Completed | - | Japan ... More >> The University of Tokyo, Graduate School of Medicine Bunkyo-ku, Tokyo, Japan, 113-8655 Less << |
NCT00786734 | Percutaneous Coronary Interven... More >>tion Less << | Phase 4 | Withdrawn | - | Korea, Republic of ... More >> Catholic University of Korea Kangnam St. Mary's Hospital Seoul, Korea, Republic of Less << |
NCT01057433 | - | Completed | - | - | |
NCT01422369 | Healthy | Phase 4 | Completed | - | United States, Texas ... More >> Austin, Texas, United States Less << |
NCT00309738 | Hypercholesterolemia ... More >> Dyslipidemia Less << | Phase 3 | Completed | - | Denmark ... More >> CCBR A/S Aalborg, Denmark CCBR A/S Ballerup, Denmark Y Forskning, Bispebjerg Hospital Copenhagen NV, Denmark Frederiks Hospital, Kardiologisk Frederiksberg, Denmark Kolesterollaboratoriet Hellerup, Denmark CCBR A/S Vejle, Denmark Netherlands Middellaan 5 Breda, Netherlands Bomanshof 8 Eindhoven, Netherlands Damsterdiep 9 Groningen, Netherlands Doezastraat 1 Leiden, Netherlands Kamerlingh Onnesstraat 16-18 Nijmegen, Netherlands Mathenesserlaan 247 Rotterdam, Netherlands Reigerstraat 30 Velp, Netherlands Parkdreef 142 Zoetermeer, Netherlands Spain Hospital Clinico S. Juan de Alicante San Juan, Alicante, Spain Hospital Clinic i Provincial Villaroel, Barcelona, Spain Hospital Universitario de Bellvitge Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Universitario Reina Sofia Cordoba, Spain Fundacion Jimenez Diaz Madrid, Spain Hospital Clinico San Carlos Madrid, Spain Hospital Ramon y Cajal Madrid, Spain Hospital Clinico Universitario de Santiago Santiago de Compostela, Spain Hospital de Sagunto Valencia, Spain Sweden Angelholms Sjukhus, Medicinkliniken Angelhom, Sweden Sahlgrenska University Hospital, Intermedicin Gothenburg, Sweden Hjartmottagningen Helsingborg, Sweden Lakarcentrum Nyponet Karineholm, Sweden Medicinkliniken Ludvika, Sweden Hjartmottagningen Malmo, Sweden Huslakaren i Sandviken Sandviken, Sweden Narsjukhuset Sandviken, Kardiologlab, Medicin Sandviken, Sweden Hjart & Karlcenter Sodertalje, Sweden Karolinska Universitetssjukhuset Stockholm, Sweden Hjarthuset AB Varberg, Sweden Less << |
NCT00653913 | Hypercholesterolemia | Phase 1 | Completed | - | - |
NCT02940366 | Metabolic Syndrome | Phase 4 | Recruiting | November 30, 2019 | Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyung-Kwan Kim, MD 82-2-2072-0243 cardiman73@gmail.com Principal Investigator: Hyung-Kwan Kim, MD Less << |
NCT00309751 | Type II Diabetes Mellitus ... More >> Dyslipidemia Less << | Phase 3 | Completed | - | Denmark ... More >> CCBR Aalborg Aalborg, Denmark CCBR A/S Ballerup, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom Less << |
NCT00309751 | - | Completed | - | - | |
NCT01422369 | - | Completed | - | - | |
NCT03730038 | Dyslipidemias | Not Applicable | Not yet recruiting | October 9, 2020 | Korea, Republic of ... More >> Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Yangsoo Jang, MD, Ph.D 82-2-2228-8460 jangys1212@yuhs.ac Less << |
NCT01301066 | Dyslipidemia | Phase 4 | Completed | - | - |
NCT00444717 | Metabolic Syndrome ... More >> Oxidative Stress Inflammation Less << | Phase 4 | Completed | - | Japan ... More >> Tatsuaki Matsubara Nagoya, Aichi, Japan, 464-8651 Less << |
NCT00889226 | Hypercholesterolemia With Type... More >>2DM Less << | Phase 4 | Completed | - | - |
NCT00309777 | - | Completed | - | - | |
NCT01301066 | - | Completed | - | - | |
NCT01043094 | - | Completed | - | - | |
NCT01043094 | Severe Renal Impairment | Phase 4 | Completed | - | United States, Minnesota ... More >> Minneapolis, Minnesota, United States Less << |
NCT00330876 | - | Completed | - | - | |
NCT01648829 | Coronary Artery Disease | Phase 4 | Unknown | December 2017 | Italy ... More >> Sapienza University Not yet recruiting Rome, Italy, 00166 Contact: Francesco Pelliccia, MD +39064997 ext 123 f.pelliccia@mclink.it Principal Investigator: Francesco Pelliccia, MD Less << |
NCT01386853 | Hyperlipidemia | Phase 3 | Unknown | July 2012 | Taiwan ... More >> Changhua Christian Hospital Not yet recruiting Chang-hua, Taiwan Principal Investigator: Chien-Hsun Hsia, M.D. Sub-Investigator: Lee-Shin Lin, M.D. National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan Principal Investigator: Ping-Yen Liu, M.D. Ph.D. Sub-Investigator: Po-Sheng Chen, M.D. Sub-Investigator: Ju-Yi Chen, M.D. Sub-Investigator: Wei-Ting Li, M.D. Sub-Investigator: Yen-Wen Liu, M.D. Sub-Investigator: Cheng-Han Lee, M.D. Sub-Investigator: Wei-Chuan Tsai, M.D. Sub-Investigator: Yi-Heng Li, M.D. Sub-Investigator: Chih-Chan Lin, M.D. Sub-Investigator: Shih-Hung Chan, M.D. Sub-Investigator: Ting-Hsing Chao, M.D. Chang Gung Memorial Hospital-LinKou Not yet recruiting Taipei, Taiwan Principal Investigator: Ming-Shien Wen, M.D. Ph.D. Sub-Investigator: Kuo-Chun Hung, M.D. Sub-Investigator: I-Chang Hsieh, M.D. Sub-Investigator: Chao-Yung Wang, M.D. Sub-Investigator: Chun-Chi Chen, M.D. National Taiwan University Hospital Not yet recruiting Taipei, Taiwan Principal Investigator: Kuo-Liong Chien, M.D. Ph.D. Sub-Investigator: Chia-Lun Chao, M.D. Sub-Investigator: Ta-Chen Su, M.D. Ph.D. Sub-Investigator: Hung-Ju Lin, M.D. Taipei Veterans General Hospital Not yet recruiting Taipei, Taiwan Principal Investigator: Tao-Cheng Wu, M.D. Ph.D. Sub-Investigator: Chin-Chou Huang, M.D. Sub-Investigator: Liang-Yu Lin, M.D. Sub-Investigator: Wen-Chung Yu, M.D. Tri-Service General Hospital Taipei, Taiwan Less << |
NCT00330876 | Hypercholesterolemia ... More >> Dyslipidemias Less << | Phase 3 | Completed | - | - |
NCT01402843 | Hypertension ... More >>Dyslipidemia Less << | Phase 3 | Completed | - | Korea, Republic of ... More >> Chungbuk National University Hospital Chung Ju, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hallym University Medical Center Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Ajou University Medical Center Suwon, Korea, Republic of Less << |
NCT00325780 | - | Completed | - | - | |
NCT00325780 | Hypercholesterolemia ... More >> Dyslipidemia Less << | Phase 3 | Completed | - | - |
NCT00344370 | - | Completed | - | - | |
NCT01256476 | - | Completed | - | - | |
NCT00344370 | Type II Diabetes Mellitus ... More >> Dyslipidemia Less << | Phase 3 | Completed | - | Denmark ... More >> CCBR Aalborg Aalborg, Denmark CCBR A/S Vejle, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom Less << |
NCT01422382 | - | Completed | - | - | |
NCT01595828 | Metabolic Syndrome | Phase 1 | Completed | - | United Kingdom ... More >> Kowa Research Europe Ltd. Wokingham, United Kingdom Less << |
NCT00846118 | Cardiovascular Disease | Not Applicable | Unknown | March 2015 | Japan ... More >> Division of Nephrology, Department of Internal Medicine, Juntendo Hospital Tokyo, Japan, 113-8421 Less << |
NCT01422382 | Healthy | Phase 4 | Completed | - | United States, Texas ... More >> Austin, Texas, United States Less << |
NCT03532620 | Prediabetic State ... More >> Hypertension Dyslipidemias Less << | Phase 4 | Recruiting | September 2020 | China, Chongqing ... More >> Fourth People's Hospital of Chongqing Recruiting Chongqing, Chongqing, China, 400014 Contact: Ruihua Yue, MD Principal Investigator: Ruihua Yue, MD China, Guangdong First Affiliated Hospital,Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Jun Tao, MD,PhD +8613922191609 taojungz123@163.com Contact: Jianning Zhang +8615521264372 ningjenny@yeah.net Principal Investigator: Jun Tao, MD,PhD Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510260 Contact: Wenchao Qu, MD Principal Investigator: Wenchao Qu, MD First Affiliated Hospital of Jinan University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Jun Guo, MD Principal Investigator: Jun Guo, MD Shenzhen People's Hospital Not yet recruiting Shenzhen, Guangdong, China, 518020 Contact: Xin Jiang, MD Principal Investigator: Xin Jiang, MD People's Hospital of Zhongshan City Recruiting Zhongshan, Guangdong, China, 528403 Contact: Li Feng, MD Principal Investigator: Li Feng, MD China, Henan First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Heping Gu, MD Principal Investigator: Heping Gu, MD China, Hubei Yichang Central Hospital Recruiting Yichang, Hubei, China, 443003 Contact: Jiawang Ding, MD Principal Investigator: Jiawang Ding, MD China, Jiangsu Taizhou Hospital of TCM Recruiting Taizhou, Jiangsu, China, 214504 Contact: Yongguang Zhang, MD Principal Investigator: Yongguang Zhang, MD Wuxi People's Hospital Recruiting Wuxi, Jiangsu, China, 214023 Contact: Ruxing Wang, MD Principal Investigator: Ruxing Wang, MD Subei People's Hospital of Jiangsu province Not yet recruiting Yangzhou, Jiangsu, China, 225001 Contact: Shenghu He, MD Principal Investigator: Shenghu He, MD China, Qinghai Lanzhou University Second Hospital Recruiting Lanzhou, Qinghai, China, 730030 Contact: Feng Bai, MD Principal Investigator: Feng Bai, MD China, Shandong Yantaishan Hospital, Yantai Not yet recruiting Yantai, Shandong, China, 264001 Contact: Lan Zhao, MD Principal Investigator: Lan Zhao, MD Less << |
NCT02290106 | Obesity Fatty... More >> Liver, Nonalcoholic Less << | Not Applicable | Completed | - | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less << |
NCT02863185 | Chronic Kidney Disease | Phase 4 | Recruiting | December 2019 | Korea, Republic of ... More >> Won Suk An Recruiting Busan, Korea, Republic of, 602-715 Contact: Won Suk An, M.D., Ph.D. +82-51-240-2811 anws@dau.ac.kr Dong-A University Not yet recruiting Busan, Korea, Republic of, 602715 Contact: Su Mi Lee, MD +822405549 promise131@hanmail.net Less << |
NCT02144922 | Hypertension ... More >>Cardiovascular Risk Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less << |
NCT01406431 | Hyperlipidemia ... More >> Hypertension Less << | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less << |
NCT01042730 | Coronary Artery Disease | Not Applicable | Unknown | March 2017 | Japan ... More >> Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Takeshi Kimura, MD +81-75-751-4254 taketaka@kuhp.kyoto-u.ac.jp Juntendo University School of Medicine Recruiting Tokyo, Japan Contact: Katsumi Miyauchi, MD, PhD +81-3-3813-3111 ktmmy@med.juntendo.ac.jp Principal Investigator: Ryozou Nagai, MD, PhD Principal Investigator: Masunori Matsuzaki, MD, PhD Sub-Investigator: Hisao Ogawa, MD, PhD Sub-Investigator: Takeshi Kimura, MD, PhD Sub-Investigator: Hiroaki Shimokawa, MD, PhD Sub-Investigator: Hiroyuki Daida, MD, PhD Less << |
NCT01871792 | Contrast-induced Nephropathy | Phase 4 | Unknown | February 2014 | Korea, Republic of ... More >> Gachon University Gil Hospital Not yet recruiting Incheon, Korea, Republic of, 405-760 Contact: Woong Chul Kang, M.D. +82-32-460-3663 kangwch@gilhospital.com Less << |
NCT01695954 | Hyperlipidemia ... More >> HIV Less << | Phase 1 | Unknown | October 2012 | United States, New York ... More >> Bellevue/NYU AIDS Clinical Trials Unit New York, New York, United States, 10016 Less << |
NCT01764178 | Hyperlipidemia ... More >> Hypertension Less << | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less << |
NCT02595268 | Healthy | Phase 1 | Completed | - | Belgium ... More >> Antwerp, Belgium Less << |
NCT03618797 | Complex-dyslipidemia | Phase 3 | Completed | - | - |
NCT02056847 | HbA1c Level Associated With Li... More >>pid Compositions Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> JW pharmaceutical Seoul, Korea, Republic of, 137-864 Less << |
NCT03717064 | Healthy Volunteers | Phase 1 | Active, not recruiting | December 17, 2018 | United States, Florida ... More >> Covance Research Unit - Daytona Daytona Beach, Florida, United States, 32117 Less << |
NCT01256476 | Primary Dyslipidemia ... More >> Mixed Dyslipidemia Less << | Phase 4 | Completed | - | - |
NCT02545231 | Atherosclerosis ... More >> Neointima Angina Less << | Phase 4 | Active, not recruiting | December 2017 | Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less << |
NCT02442700 | HIV Dyslipide... More >>mia Less << | Phase 4 | Completed | - | - |
NCT02442700 | - | Completed | - | - |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.37mL 0.47mL 0.24mL |
11.86mL 2.37mL 1.19mL |
23.73mL 4.75mL 2.37mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|